Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (2)
  • Endogenous Metabolite
    (2)
  • Microtubule Associated
    (2)
  • PROTACs
    (2)
  • Phosphatase
    (2)
  • BTK
    (1)
  • Beta Amyloid
    (1)
  • DNA Alkylation
    (1)
  • FGFR
    (1)
  • Others
    (15)
Filter
Search Result
Results for "

aberrant

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    33
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    2
    TargetMol | Compound_Libraries
  • Dye Reagents
    2
    TargetMol | Dye_Reagents
  • PROTAC Products
    4
    TargetMol | PROTAC
  • Natural Products
    2
    TargetMol | Natural_Products
  • Recombinant Protein
    13
    TargetMol | Recombinant_Protein
Aberrant tau degrader 2
T2053112417159-58-9
Aberrant tau degrader 2 (Compound 4-12) acts as a degrader of tau protein and serves as a target protein ligand for the synthesis of PROTAC degrader C004019.
  • Inquiry Price
Size
QTY
Aberrant tau ligand 1
T879981892461-96-9
  • Inquiry Price
Size
QTY
DB1113
T746422769753-53-7
DB1113 (Example 24) is a bifunctional compound designed for the targeted degradation of various kinases, including ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2, MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1, RPS6KA1, RPS6KA3, SIK2, SIK3, STK35, TNK2, and ULK1. This capability positions DB1113 as a valuable tool for research into diseases or disorders associated with aberrant kinase activity [1].
  • Inquiry Price
Size
QTY
DB0614
T746442769753-47-9
DB0614 (Example 21) is a bifunctional compound designed for the targeted degradation of kinases, effectively breaking down AAK1, AURKA, BMP2K, CAMKK1, CDK16, CML, CDK6, EIF2AK2, FER, GAK, LCK, LIMK2, MAP3KH, MAPK8, MAPK9, NEK9, PLK4, PTK2B, SIK2, STK17A, STK17B, ULK1, ULK3, and WEE1. This compound has potential applications in research on diseases or disorders caused by aberrant kinase activity [1].
  • Inquiry Price
Size
QTY